Form 4: Thermo Fisher Scientific SVP Michael Boxer Executes Stock Option and Sells Shares

Thermo Fisher Scientific's SVP and General Counsel, Michael A. Boxer, exercised stock options and sold shares on July 26, 2024, according to a Form 4 filing with the SEC.

Summary

• Michael A. Boxer, SVP and General Counsel of Thermo Fisher Scientific, executed a transaction involving the company's stock on July 26, 2024.
• Boxer exercised stock options to acquire 2,000 shares of common stock at a price of $210.68 per share.
• Simultaneously, Boxer sold 2,000 shares of common stock at $600.85 per share.
• Following these transactions, Boxer directly owns 13,083.172 shares of Thermo Fisher Scientific.
• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 13, 2023.
• The stock option was granted with an exercise price of $210.68 and vested in four equal installments between February 2019 and February 2022.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reflects routine transactions by an insider under a pre-arranged trading plan. There is no indication of positive or negative sentiment towards the company's prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the increased transparency of insider trading activities.
• The transactions do not appear to have a direct impact on employees, customers, suppliers, or creditors.

Key Dates